Physician profile
Michael Elsenbeck
NPI 1164832176
$17,670.91
in general payments reported to CMS, 2019-2025
9 companies · $4,000 in 2025
The $4,000 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $2,101 · 2021: $6,373 · 2022: $2,082 · 2023: $1,308 · 2024: $1,571 · 2025: $4,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,049 · Food and Beverage: $2,330 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,049.06 |
| Food and Beverage | $2,329.64 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $6,331.75 | 2020-2023 | |
| Encore Medical, LP | $4,224.54 | 2023-2025 | Djo Surgical |
| Arthrex, INC. | $3,450.68 | 2021-2022 | |
| Stryker Corporation | $1,718.86 | 2024-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform+ |
| Supreme Orthopedic Systems, LLC | $918.32 | 2020 | |
| Coastal Medical Technologies LLC | $609.96 | 2025 | |
| Smith+Nephew, INC. | $236.46 | 2019 | |
| Next Science LLC | $135.52 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $44.82 | 2022-2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Elsenbeck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.